Literature DB >> 10611179

Severe OHSS: how many cases are preventable?

P E Egbase1.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10611179     DOI: 10.1093/humrep/15.1.8

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  5 in total

1.  Recombinant follitropin alfa/lutropin alfa in fertility treatment.

Authors:  Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Biologics       Date:  2010-02-04

2.  Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?

Authors:  Ya-Qin Wang; Jin Luo; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jin Yang
Journal:  J Ovarian Res       Date:  2015-09-23       Impact factor: 4.234

3.  Cetrotide administration in the early luteal phase in patients at high risk of ovarian hyperstimulation syndrome: A controlled clinical study.

Authors:  Ya-Qin Wang; Nan Yu; Wang-Min Xu; Qin-Zhen Xie; Wen-Jie Yan; Geng-Xiang Wu; Jing Yang
Journal:  Exp Ther Med       Date:  2014-10-06       Impact factor: 2.447

4.  Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation.

Authors:  V Giner; M R Oltra; M J Esteban; M J García-Fuster; A Salvador; J Núñez; J Redón
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 3.650

Review 5.  Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Authors:  Mohamed A Youssef; Selma Mourad
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.